4Filing Date: May 6, 2026
West Pharmaceutical Services (WST)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0000105770-26-000062
Total Value$0
Trades1
Insiders1
Transaction Details
Keller Deborah L
Director·Direct
Grant · Acquire
Common Stock
Shares+791
Price$0.00
Total Value$0
Shares Owned After11.56K
Transaction DateMay 4, 2026
Footnotes ▸
These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting.
Post-Transaction Holdings
Keller Deborah L · Director
| Security | Shares | Change |
|---|---|---|
| Common Stock | 11.56K | +791 (7.34%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-05-04
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
--- Reporting Owner ---
Name: Keller Deborah L
CIK: 0001352992
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-05-04 | Code: A (Grant or award)
Shares: +791 | Price: $0.00
Shares Owned After: 11,560.479 | Ownership: D (Direct)
Footnotes:
[F1] These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting.
--- Footnotes (Complete Index) ---
F1: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting.
--- Signature ---
/s/ /s/ Louis Lalli, as an agent for Deborah L. Keller (2026-05-06)